Notably, the results showed that the tumor PET signal was a more reliable predictor of PD‐L1 inhibitor efficacy than PD‐L1 levels determined through IHC or RNA‐sequencing.[3] Long half‐life radioisotopes such as 89Zr exhibit a more favorable compatibility with antibodies but also bring longer imaging time window. This evidence concerns the gene CD274 and neoplasm.